Status:
UNKNOWN
High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood
Lead Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Conditions:
Medulloblastoma
Brain Tumors
Eligibility:
All Genders
Up to 10 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the efficacy of the combination of surgery, conventional chemotherapy, sequential high-dose chemotherapy with peripheral blood stem cell transplantation and re...
Eligibility Criteria
Inclusion
- Medulloblastoma in patients less than 5 years of age
- Brain PNET in patients less than 10 years of age
- Histologically documented diagnosis
- Body weight of \> 8 kg
Exclusion
- Parents' refusal
Key Trial Info
Start Date :
July 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT00180791
Start Date
July 1 2002
Last Update
September 18 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Gustave Roussy
Villejuif, France, 94800